Breast cancer resistance protein (BCRP) inhibitor

Details for Australian Patent Application No. 2004210259 (hide)

Owner Kabushiki Kaisha Yakult Honsha

Inventors Aiyama, Ritsuo; Nishiyama, Yukiko; Hashimoto, Shusuke; Matsuzaki, Takeshi; Nagaoka, Masato; Yoshida, Oh; Yamazaki, Ryuta; Furuta, Tomio; Sugimoto, Yoshikazu; Hatano, Hiroshi

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004210259

PCT Pub. Number WO2004/069243

Priority 2003-026856 04.02.03 JP

Filing date 3 February 2004

Wipo publication date 19 August 2004

Acceptance publication date 11 December 2008

International Classifications

A61K 31/277 (2006.01)

A61K 31/7034 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07C 255/37 (2006.01) Carboxylic acid nitriles

Event Publications

25 August 2005 PCT application entered the National Phase

  PCT publication WO2004/069243 Priority application(s): WO2004/069243

11 December 2008 Application Accepted

  Published as AU-B-2004210259

9 April 2009 Standard Patent Sealed

26 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004210266-Inhibitor for perioperative blood sugar elevation

2004210246-Combination of antidiabetic drugs